Display options
Share it on

HIV AIDS (Auckl). 2021 Aug 18;13:829-838. doi: 10.2147/HIV.S323090. eCollection 2021.

Levels of Adherence and Associated Factors Among Children on ART Over Time in Northwest, Ethiopia: Evidence from a Multicenter Follow-Up Study.

HIV/AIDS (Auckland, N.Z.)

Fisha GebreEyesus, Dagninet Mitku, Tadesse Tarekegn, Bogale Temere, Tamene Terefe, Amsalu Belete, Getasew Legas, Dejen Feleke, Moges Gelaw Taye, Nega Baye, Fitalew Admasu, Enyew Dagnew, Tewachew Liyeh, Melkamu Jimma, Ermias Chanie

Affiliations

  1. Department of Nursing, College of Medicine and Health Sciences, Wolkite University, Wolkite, Ethiopia.
  2. DebreTabor University, DebreTabor, Ethiopia.
  3. Department of Nursing, College of Health Sciences, Assosa University, Assosa, Ethiopia.

PMID: 34434060 PMCID: PMC8380805 DOI: 10.2147/HIV.S323090

Abstract

BACKGROUND: Despite the increased availability of antiretroviral therapy (ART), its success depends on a high level of adherence to a life-long antiretroviral therapy. However, the extent and factors associated with adherence to ART are not well known, especially in the current study setup. Therefore, this study aimed to assess the level of adherence and associated factors among children on ART in Northwest, Ethiopia.

METHODS: A retrospective follow-up study was conducted on human immunodeficiency virus (HIV)-infected children receiving ART at South Gondar public hospitals. Children receiving ART from January 1, 2015, to November 30, 2020, were included in the study. A computer-generated simple random sampling technique was employed. The data were entered into the EpiData version 3.1 and analyzed by STATA 14 statistical software. Bivariable logistic regression was fitted for each predictor variable. Moreover, those variables having a p-value ≤0.25 in bivariate analysis were fitted into a multivariable logistic regression model. P-value <0.05 was used to declare significance.

RESULTS: A total of 363 HIV-infected children were involved in the study. From 363 HIV-infected children, the level of adherence to ART was found to be 78.2%, 95% CI (73.6, 82.2). TB co-infection [adjusted odds ratio (AOR) = 3.8, 95% CI (1.41, 10.1)], short duration on ART (AOR = 3.4, 95% CI (1.60, 7.20)), treatment failure (AOR = 10.2, 95% CI (3.95, 26.2)), and Zidovudine containing ART regimen (AOR = 3.5, 95% CI (1.1, 10.9)) were significant predictors of poor adherence.

CONCLUSION: The current study showed that the level of adherence to ART was found to be low TB co-infection, short duration of ART, Zidovudine-containing ART regimen, and treatment failure were found to be significantly associated with poor adherence. Further studies on adherence rate and its determinants with multiple adherence measurements using prospective and multicenter studies were recommended.

© 2021 GebreEyesus et al.

Keywords: ART; Ethiopia; adherence; children

Conflict of interest statement

The authors report no conflicts of interest in this work.

References

  1. AIDS Care. 2011 Jul;23(7):831-8 - PubMed
  2. J Pediatr Psychol. 2006 Oct;31(9):989-94 - PubMed
  3. BMC Infect Dis. 2015 Jan 31;15:28 - PubMed
  4. Ann Intern Med. 2000 Jul 4;133(1):21-30 - PubMed
  5. PLoS One. 2018 May 22;13(5):e0197145 - PubMed
  6. AIDS Care. 2017 Apr;29(4):436-440 - PubMed
  7. Pediatrics. 2007 Jun;119(6):e1371-83 - PubMed
  8. PLoS One. 2019 Mar 21;14(3):e0214014 - PubMed
  9. BMC Health Serv Res. 2008 Nov 20;8:241 - PubMed
  10. PLoS Med. 2007 Oct 16;4(10):e298 - PubMed
  11. BMC Res Notes. 2019 Mar 22;12(1):162 - PubMed
  12. BMC Pediatr. 2013 Sep 02;13:132 - PubMed
  13. Pharmacol Res Perspect. 2017 Jan 25;5(1):e00296 - PubMed
  14. Curr HIV/AIDS Rep. 2009 Nov;6(4):194-200 - PubMed
  15. Niger J Clin Pract. 2011 Apr-Jun;14(2):206-11 - PubMed
  16. BMC Pediatr. 2008 Dec 06;8:53 - PubMed
  17. AIDS Res Ther. 2019 Aug 28;16(1):22 - PubMed
  18. BMC Infect Dis. 2020 Jan 16;20(1):50 - PubMed
  19. BMC Public Health. 2019 Jun 10;19(1):720 - PubMed
  20. BMC Pediatr. 2008 Sep 04;8:34 - PubMed
  21. Lancet. 2007 Jul 7;370(9581):68-80 - PubMed
  22. Infect Disord Drug Targets. 2011 Apr;11(2):167-74 - PubMed
  23. HIV AIDS (Auckl). 2015 Mar 11;7:75-81 - PubMed
  24. Health Psychol. 2006 Mar;25(2):153-62 - PubMed
  25. J Behav Med. 2008 Jun;31(3):213-24 - PubMed
  26. BMC Res Notes. 2018 Jul 13;11(1):466 - PubMed
  27. BMC Public Health. 2014 Apr 15;14:365 - PubMed
  28. Antivir Ther. 2013;18(5):681-90 - PubMed
  29. J Int AIDS Soc. 2016 Jun 30;19(1):20917 - PubMed
  30. Indian J Dermatol Venereol Leprol. 2005 Sep-Oct;71(5):316-20 - PubMed
  31. Pan Afr Med J. 2013 Sep 29;16:30 - PubMed
  32. BMC Public Health. 2020 Jan 20;20(1):82 - PubMed
  33. J Acquir Immune Defic Syndr. 2015 Jun 1;69(2):e49-56 - PubMed
  34. Pediatrics. 2006 Dec;118(6):e1745-57 - PubMed
  35. Sao Paulo Med J. 2019 Nov-Dec;137(6):479-485 - PubMed
  36. Pediatr Infect Dis J. 2008 Aug;27(8):686-91 - PubMed

Publication Types